Insider trades
OrbiMed Genesis GP, Director of ADARx Pharmaceuticals ADRX, has filed 53 purchases and 103 sales on the open market. Over the past 12 months that comes to a net purchase of $16.3M. The latest trade was on 09/28.
OrbiMed Genesis GP
Director
- Company
- ADARx Pharmaceuticals ADRX
- First filing
- 23/01/03
- Trades
- 227 trades
- Buys / sales
- 53 / 103
- 12-month net buying
- $16.3M
- Last trade
- 09/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ADRX | Open-market buy | 09/28 | 09/30 | 950,000 sh3 trades | $17.00avg. | $16,150,000 | No record |
ETRA | Open-market buy | 09/21 | 09/23 | 1,333,333 sh2 trades | $15.00avg. | $19,999,995 | +313.8% |
ELVN | Open-market sale | 06/22 | 06/24 | 860,123 sh4 trades | $45.36avg. | $39,014,045.6 | −11.6% |
ELVN | Open-market sale | 06/15 | 06/17 | 281,408 sh2 trades | $45.02avg. | $12,668,988.16 | −3.7% |
QTTB | Open-market buy | 05/28 | 06/01 | 1,875,000 sh2 trades | $8.00avg. | $15,000,000 | No record |
PRLD | Open-market buy | 04/21 | 04/23 | 2,815,315 sh2 trades | $4.44avg. | $12,499,998.6 | No record |
ACET | Open-market sale | 04/07–04/08 | 04/09 | 104,658 sh4 trades | $6.45avg. | $674,847.06 | −100.0% |
ACET | Open-market buy | 25/10/08 | 25/10/10 | 5,000,000 sh2 trades | $1.00avg. | $5,000,000 | No record |
STTK | Open-market buy | 25/08/25 | 25/09/02 | 6,306,127 sh2 trades | $0.87avg. | $5,486,330.49 | No record |
| Open-market sale | 25/04/09 | 25/04/11 | 3,571,428 sh | $1.59 | $5,678,570.52 | −100.0% | |
EWTX | Open-market buy | 25/04/03 | 25/04/04 | 496,771 sh2 trades | $20.13avg. | $10,000,000.23 | No record |
IRON | Open-market sale | 25/03/24 | 25/03/26 | 5,738 sh3 trades | $54.11avg. | $310,483.18 | −3.0% |
IRON | Open-market sale | 25/03/19–25/03/21 | 25/03/21 | 52,429 sh9 trades | $54.02avg. | $2,831,986.74 | −21.9% |
IRON | Open-market sale | 25/03/10–25/03/12 | 25/03/12 | 312,384 sh15 trades | $54.31avg. | $16,965,596.07 | −61.7% |
MBX | Open-market buy | 25/02/14–25/02/18 | 25/02/19 | 190,672 sh4 trades | $10.60avg. | $2,020,755.6 | +34.2% |
MBX | Open-market buy | 24/09/16 | 24/09/17 | 750,000 sh2 trades | $16.00avg. | $12,000,000 | No record |
| Open-market buy | 24/08/13 | 24/08/15 | 500,000 sh2 trades | $4.00avg. | $2,000,000 | No record | |
KROS | Open-market sale | 24/08/13 | 24/08/15 | 250,000 sh2 trades | $44.01avg. | $11,002,500 | −67.7% |
| Open-market sale10b5-1 plan | 24/07/15–24/07/16 | 24/07/17 | 56,164 sh6 trades | $10.00avg. | $561,640 | −6.9% | |
IRON | Open-market buy | 24/06/17 | 24/06/20 | 83,334 sh3 trades | $36.00avg. | $3,000,024 | +54.8% |
